Related Experiment Videos
[Stroke prevention].
M Arnold1, K Nedeltchev, Ph Lyrer
1Neurologische Universitätskliniken Bern. marcel.arnold@insel.ch
Therapeutische Umschau. Revue Therapeutique
|October 29, 2003
Summary
Lifestyle changes and medications like antihypertensives and antithrombotics can reduce stroke risk. Antiplatelet agents and warfarin are key for preventing recurrent strokes and managing specific conditions.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Lifestyle modifications are crucial for reducing stroke risk.
- Several drug classes, including antihypertensives, antidiabetics, statins, and antithrombotics, are effective in managing patients with stroke risk factors.
Purpose of the Study:
- To review the pharmacological strategies for stroke risk reduction and secondary stroke prevention.
- To outline the primary and alternative medication choices for different stroke types and patient profiles.
Main Methods:
- Review of established pharmacological treatments for stroke prevention.
- Analysis of antiplatelet agents and anticoagulants in secondary stroke prevention.
Main Results:
- Antiplatelet agents (aspirin, aspirin/dipyridamole, clopidogrel) are first-line for non-cardioembolic ischemic stroke prevention.
- Warfarin is effective for cardioembolic stroke, cerebral venous thrombosis, and antiphospholipid antibody syndrome, with other potential indications.
Conclusions:
- Pharmacological interventions, tailored to stroke type and patient factors, are essential for secondary stroke prevention.
- Antiplatelet therapy and anticoagulation with warfarin represent cornerstone treatments in managing cerebrovascular disease.